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Abstract
Leukocyte adhesion deficiency 1 (LAD-1) is a rare autosomal recessive disorder of leukocyte function due to integrin deficiency. It is 
characterized by recurrent bacterial and fungal infections and depressed inflammatory responses despite striking blood neutrophilia. 
Severe LAD usually presents early in infancy. Here, we report a case who presented late with symptoms of LAD-1 when compared with 
earlier reported cases and without the usually associated infections.
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Leukocyte adhesion defect is a rare form of immunodeficiency disorder with an incidence of 1 in 10 million individuals [1]. It is usually characterized 
by recurrent bacterial and fungal infection. Patients with 
leukocyte adhesion deficiency (LAD) have impaired 
neutrophil chemotaxis leading to neutrophilia and absence of 
pus formation [1]. Children with severe LAD-1 disease are 
normally infants with recurrent, indolent bacterial infections 
of the skin, mouth, respiratory tract, lower intestinal tract, and 
genital mucosa. We are reporting a case of this disorder with 
late presentation and without the usually associated infections. 
To the best of our knowledge, this is the third case of LAD-1 
reported in Indian children who have late presentation.
CASE REPORT
A 20-month-old developmentally normal female toddler born 
out of non-consanguineous marriage brought with high-grade 
fever (104°F) of 2 days. Her systemic examinations were normal 
including eyes, ears, nose, mouth and throat with no dysmorphic 
features [1]. Her weight was 12.4 kg; length was 83.7 cm and 
HC 48 cm (normal for her age). She was born to a primi mother 
at hospital with birth weight of 2.78 kg with uneventful antenatal 
and postnatal period and history of cord separation at day 5 with 
no significant family history. Her immunization was up to date, 
and she was otherwise growing well.
This was the third hospital admission within a span of 
6 months (first admission at 14 months of age), each time for 
fever without focus. Her anthropomertic parameter remained 
within normal range with no weight loss over a period of 
6 months. On laboratory investigations, complete blood count 
showed leukocytosis and striking neutrophilia (total leucocyte 
count [TLC] - 32,700/mm3 and neutrophil 23,544/mm3) at 
the time of first admission. Subsequently, her TLC decreased 
after a course of antibiotic (ceftrioxone for 7 days), but 
remained in high range (26,000/mm3) with neutrophil count 
of 18,000/mm3 during afebrile period. At second admission 
(age 17 months), her TLC was 56,000/mm3 with predominant 
neutrophils (absolute neutrophil count = 45,846/mm3). She was 
treated with broad spectrum antibiotics injection cefrioxone 
and amikacin for 7 days. Echocardiogram was not done and 
parents did not give consent for bone marrow examination. 
On this admission (age 20 months), the peripheral neutrophil 
count was 24,092/mm3. Other investigations done to search 
the focus including blood culture, urine routine, urine culture, 
chest X-ray and ultrasonography (kidneys, ureters, and urinary 
bladder) were normal on all three occasions. Erythrocyte 
sedimentation rate was 20-25 mm/h, C-reactive protein was 
elevated (36-128 mg/dl) in all three admissions. She was treated 
with piperacillin and tazobactam plus amikacin for 10 days and 
investigated for immunodeficiency.
Her CD4/CD8 was 3.14 (normal: 1.2-6.2), human 
immunodeficiency virus enzyme-linked immunosorbent assay 
negative, serum immunoglobulin G was 823 mg/dl (normal for 
age: 290-1070 mg/dl), IgM 72 mg/dl (normal: 40-150 mg/dl), 
IgA 58 mg/dl (normal: 15-90 mg/dl) and serum IgE level was 
126.36 mg/dl (normal <35.00), which was not significantly 
raised. Nitroblue-tetrazolium was also negative, and there were 
no Chediak–Higashi granules on peripheral smear. CD11a/
CD18 was 13.3% (control 48.2%), CD11b 97.4% (control 
93.4%), and CD11c/CD18 96.7% (control 94.5%) by flow 
cytometry method leading to diagnosis of LAD-1. Since, 
March 2013 she is on cotrimoxazole prophylaxis and currently 
asymptomatic and growing well with weight for age 15.4 kg 
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and length for age 97.3 cm at 36 months of age with neutrophil 
counts (4420/mm3). Parents were counseled regarding the 
nature of disease and treatment options available.
DISCUSSION
Leukocyte adhesion defect is an autosomal recessive 
immunodeficiency disorder [1]. It was first recognized as 
a clinical entity in 1970. Neonates with LAD-1 may have a 
history of delayed cord separation [2-4], usually with associated 
infection (omphalitis) [1]. The adhesion defect leads to poor 
neutrophil chemotaxis, phagocytosis and neutrophilia [3]. 
Individuals with LAD suffer from bacterial infections beginning 
in the neonatal period. Infections such as omphalitis, 
pneumonia, gingivitis and periodontitis are common and often 
life-threatening due to the infant’s inability to properly destroy 
the invading pathogens [2-3]. These individuals do not form 
an abscess because granulocytes cannot migrate to the sites of 
infection.
The inherited molecular defect in patients with LAD is a 
deficiency of the β-2 integrin sub-unit, also called CD18, of the 
leukocyte cell adhesion molecule, which is found on chromosome 
21 [1]. This defective gene creates a non-functioning protein 
resulting in lack of lymphocyte function-associated antigen 
1 integrin (CD11a/CD18), which allows neutrophils to make 
their way out of the blood stream by adhering to the Ig family 
receptor intercellular adhesion molecule 1 on the apical surface 
of endothelial cells in the infected areas of the body [5]. The 
bacteria can then proliferate, leading to symptomatic infection. 
The infection can then spread unimpeded and cause serious 
injury to important tissue. In LAD-1, the integrin system is 
defective while in LAD-2, selectin system is defective [1]. The 
four different chains of the leukocyte integrin family (CD11a, 
11b, 11c, CD11d) are dependent on one beta chain (CD-18) for 
proper insertion into the cell membrane [1]. Mutations in the 
CD18 gene either impair gene expression or affect the structure 
of synthesized CD18 peptide, leading to functionally abnormal 
CD11/CD18.
In general, diagnosis is done after several preliminary tests 
of immune functions, including basic evaluation of the humoral 
immune system and the cell-mediated immune system. A WBC 
differential will reveal extremely elevated levels of neutrophils 
(on the order of 6-10 × normal) because they are unable to leave 
the blood vessels. Patients with severe form of LAD-1 have 
<0.3% of the normal amount of β2-integrin molecules, whereas 
patients with moderate phenotype may have 2-7% of the normal 
amount [1]. The severity of infectious complications correlates 
with a degree of β-2 integrin deficiency. Patients with moderate 
deficiency have an infrequent life-threatening infections and 
relatively long survival [1,5]. In our case it was 13.3%, which 
probably explains the late presentation and fever without focus 
and behaved like milder form of moderate LAD-1.
Once the diagnosis of a severe LAD is made, bone marrow 
transplantation is the current standard cure [6]. However, 
some progress has been made in gene therapy, an active area 
of research [7]. Antibiotic prophylaxis and gamma interferon 
have a supportive role [7]. Patients can be maintained on 
trimethoprim-sulfamethoxazole prophylaxis and should 
have close surveillance for early identifications of infections 
and initiations of empirical treatment with broad spectrum 
antibiotics [1]. Prenatal diagnosis is possible by identifying 
deficiency or absence of leukocyte adhesion (leu CAM) on 
leukocyte using monoclonal antibody [8].
The normal neonatal period with late presentation as fever 
without focus with peripheral neutrophilia makes our case 
unique. To the best of our knowledge, this is the third case 
reported in an Indian child [9]. Having a high index of suspicion 
even in the absence of typical clinical features of this disorder 
may lead to early evaluation and diagnosis.
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